March 3, 2026 · Form 4 insider transaction
Oelschlager Kristen M bought 48,367 shares of Castle Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.; The RSU's vest in four equal annual installments beginning on March 03, 2027.